Medical management of primary pulmonary hypertension (Q33147339)

22 July 2017

1 reference

title

Medical management of primary pulmonary hypertension (English)

1 reference

primary pulmonary hypertension

22 July 2017

1 reference

based on heuristic

inferred from title

author name string

Vallerie V McLaughlin

series ordinal

1

1 reference

PubMed ID

11829729

22 July 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Expert Opinion on Pharmacotherapy

22 July 2017

1 reference

22 July 2017

3

1 reference

22 July 2017

2

1 reference

22 July 2017

159-165

1 reference

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

22 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.2.159

21 January 2018

Identifiers

DOI

10.1517/14656566.3.2.159

1 reference

22 July 2017

1 reference

PubMed ID

11829729